Seronegative AE: Is Cancer Screening Needed for Me?

Yes, an evaluation for underlying cancer is generally considered, but the extent and urgency of testing will be personalized to your specific situation. Even if no autoimmune encephalitis (AE) antibodies were found in your blood or spinal fluid—a status known as being seronegative—this does not automatically rule out an underlying tumor ^[1]. However, it is important to remember that many people with seronegative AE will not have cancer ^[2].

Paraneoplastic vs. Non-Paraneoplastic Autoimmune Encephalitis

Autoimmune encephalitis occurs when your immune system mistakenly attacks healthy brain cells. Sometimes, this is triggered by an underlying cancer somewhere else in the body. When this happens, it is called a paraneoplastic syndrome. The immune response to a tumor—which can involve antibodies, immune cells (like T-cells), or both—mistakenly affects the nervous system ^[1].

Treating a hidden tumor is very important because it improves the chance of controlling the neurological syndrome. However, treating the cancer is not a guaranteed immediate cure for the encephalitis; you may still need separate neurological therapies to treat the brain inflammation ^[3][4].

If no tumor is found after appropriate evaluation and follow-up, the disease is considered non-paraneoplastic. Keep in mind that the absence of a recognized antibody does not guarantee the disease is non-paraneoplastic, as tumors have been found in comprehensively evaluated seronegative AE cases ^[2][5].

Factors That Guide Your Screening

Doctors do not use a single, identical screening test for everyone. Instead, they look at your overall health to estimate your risk and guide testing ^[6]. Your care team will consider:

• Your demographics and risks: Your age, the organs you have, your family history, and lifestyle factors like a history of smoking ^[6][4].
• Your clinical phenotype: This is the specific pattern of neurological symptoms and physical examination findings you are experiencing.
• Systemic symptoms: Symptoms that affect the body outside the brain—such as unexplained weight loss, drenching night sweats, or newly enlarged lymph nodes—will significantly raise the suspicion of a tumor ^[1].

How Doctors Look for Hidden Tumors

Your doctor will likely use a stepwise approach to look for potential tumors:

1. Routine Age-Appropriate Screening: You should be up to date on established screening tests for your age and anatomy, such as mammograms, cervical screening (Pap smears), or colorectal screening.
2. Targeted Imaging: A computed tomography (CT) scan of the chest, abdomen, and pelvis is one common approach when doctors strongly suspect a paraneoplastic cause ^[7]. However, doctors will weigh this against the risks of radiation exposure and contrast dye, meaning extensive CT scans are not automatically appropriate for everyone.
3. Advanced Imaging: If standard scans are clear but clinical suspicion remains high, doctors may consider a whole-body FDG-PET/CT scan. This is a selective second-line option that looks for metabolically active areas in the body ^[7][8]. While useful, PET scans have limitations: they can miss slow-growing tumors with low metabolism and can falsely flag harmless inflammation or infection.

Understanding Your Results: A clear scan is very reassuring, though not an absolute guarantee. If an abnormality is found, it does not automatically mean cancer. “Incidental findings” (like harmless cysts or benign nodules) are common and may simply require a follow-up scan or a targeted biopsy to confirm they are safe.

The Role of Surveillance (Repeat Screening)

In some paraneoplastic cases, a tumor is too small to be seen on imaging when the neurological symptoms first begin, only to emerge months or even years later ^[9][10]. Because of this, planned follow-up testing (known as surveillance) is sometimes necessary.

There is no universal rule for how long to keep checking. For certain high-risk phenotypes, doctors might repeat imaging every few months initially, while lower-risk seronegative cases may have a much less intensive plan. Depending on the case, experts sometimes consider ongoing follow-up screening for a few years ^[11]. Your neurologist will set a timeline tailored to your specific risk.

When to Contact Your Doctor: If your neurological symptoms suddenly relapse or worsen, you should contact your care team promptly for a clinical review. A relapse does not automatically mean cancer has appeared—it could be caused by an infection, a medication issue, or the natural course of the autoimmune disease—but it may prompt your doctor to renew cancer screening or re-test your antibodies ^[10].